Logo image of ULCC

FRONTIER GROUP HOLDINGS INC (ULCC) Stock Fundamental Analysis

NASDAQ:ULCC - Nasdaq - US35909R1086 - Common Stock

8.58  +0.32 (+3.87%)

After market: 8.57 -0.01 (-0.12%)

Fundamental Rating

2

Overall ULCC gets a fundamental rating of 2 out of 10. We evaluated ULCC against 23 industry peers in the Passenger Airlines industry. ULCC may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, ULCC is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ULCC has reported negative net income.
ULCC had a negative operating cash flow in the past year.
In the past 5 years ULCC reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: ULCC reported negative operating cash flow in multiple years.
ULCC Yearly Net Income VS EBIT VS OCF VS FCFULCC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M -400M

1.2 Ratios

The Return On Assets of ULCC (-0.10%) is better than 60.87% of its industry peers.
ULCC has a Return On Equity (-1.09%) which is comparable to the rest of the industry.
ULCC has a Return On Invested Capital of 0.21%. This is comparable to the rest of the industry: ULCC outperforms 47.83% of its industry peers.
Industry RankSector Rank
ROA -0.1%
ROE -1.09%
ROIC 0.21%
ROA(3y)-1.15%
ROA(5y)-0.66%
ROE(3y)-9.56%
ROE(5y)-10.99%
ROIC(3y)N/A
ROIC(5y)N/A
ULCC Yearly ROA, ROE, ROICULCC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

1.3 Margins

ULCC has a Operating Margin (0.30%) which is comparable to the rest of the industry.
ULCC has a Gross Margin (52.97%) which is in line with its industry peers.
In the last couple of years the Gross Margin of ULCC has declined.
Industry RankSector Rank
OM 0.3%
PM (TTM) N/A
GM 52.97%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.74%
GM growth 5Y-2.37%
ULCC Yearly Profit, Operating, Gross MarginsULCC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

More info and screens

1

2. Health

2.1 Basic Checks

ULCC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
ULCC has more shares outstanding than it did 1 year ago.
ULCC has a better debt/assets ratio than last year.
ULCC Yearly Shares OutstandingULCC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 50M 100M 150M 200M
ULCC Yearly Total Debt VS Total AssetsULCC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 0.72, we must say that ULCC is in the distress zone and has some risk of bankruptcy.
ULCC has a Altman-Z score of 0.72. This is in the lower half of the industry: ULCC underperforms 60.87% of its industry peers.
ULCC has a Debt/Equity ratio of 0.51. This is a neutral value indicating ULCC is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.51, ULCC belongs to the top of the industry, outperforming 82.61% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Altman-Z 0.72
ROIC/WACC0.03
WACC8.43%
ULCC Yearly LT Debt VS Equity VS FCFULCC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M

2.3 Liquidity

ULCC has a Current Ratio of 0.53. This is a bad value and indicates that ULCC is not financially healthy enough and could expect problems in meeting its short term obligations.
ULCC's Current ratio of 0.53 is on the low side compared to the rest of the industry. ULCC is outperformed by 65.22% of its industry peers.
ULCC has a Quick Ratio of 0.53. This is a bad value and indicates that ULCC is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.53, ULCC is not doing good in the industry: 60.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.53
Quick Ratio 0.53
ULCC Yearly Current Assets VS Current LiabilitesULCC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

5

3. Growth

3.1 Past

ULCC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.00%.
Looking at the last year, ULCC shows a small growth in Revenue. The Revenue has grown by 1.66% in the last year.
The Revenue has been growing by 10.73% on average over the past years. This is quite good.
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
Revenue 1Y (TTM)1.66%
Revenue growth 3Y42.13%
Revenue growth 5Y10.73%
Sales Q2Q%5.89%

3.2 Future

ULCC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 112.90% yearly.
ULCC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.67% yearly.
EPS Next Y-61.36%
EPS Next 2Y120.89%
EPS Next 3Y112.9%
EPS Next 5YN/A
Revenue Next Year4.09%
Revenue Next 2Y9.2%
Revenue Next 3Y10.67%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ULCC Yearly Revenue VS EstimatesULCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
ULCC Yearly EPS VS EstimatesULCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 -1 -1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Forward Earnings ratio of 15.99 indicates a correct valuation of ULCC.
ULCC's Price/Forward Earnings ratio is in line with the industry average.
When comparing the Price/Forward Earnings ratio of ULCC to the average of the S&P500 Index (24.11), we can say ULCC is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 15.99
ULCC Price Earnings VS Forward Price EarningsULCC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

ULCC's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ULCC is more expensive than 60.87% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 23.42
ULCC Per share dataULCC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

ULCC's earnings are expected to grow with 112.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y120.89%
EPS Next 3Y112.9%

More info and screens

0

5. Dividend

5.1 Amount

ULCC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRONTIER GROUP HOLDINGS INC

NASDAQ:ULCC (1/17/2025, 8:00:01 PM)

After market: 8.57 -0.01 (-0.12%)

8.58

+0.32 (+3.87%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)10-29 2024-10-29/bmo
Earnings (Next)02-11 2025-02-11/amc
Inst Owners23.42%
Inst Owner Change0%
Ins Owners46.12%
Ins Owner Change0.33%
Market Cap1.93B
Analysts68.89
Price Target7 (-18.41%)
Short Float %26.65%
Short Ratio6.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-32.79%
Min EPS beat(2)-76.2%
Max EPS beat(2)10.62%
EPS beat(4)3
Avg EPS beat(4)21.52%
Min EPS beat(4)-76.2%
Max EPS beat(4)100%
EPS beat(8)7
Avg EPS beat(8)17.55%
EPS beat(12)10
Avg EPS beat(12)17.11%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.89%
Min Revenue beat(2)-7.07%
Max Revenue beat(2)-2.7%
Revenue beat(4)0
Avg Revenue beat(4)-3.39%
Min Revenue beat(4)-7.07%
Max Revenue beat(4)-1.57%
Revenue beat(8)0
Avg Revenue beat(8)-3.42%
Revenue beat(12)1
Avg Revenue beat(12)-3.4%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3%
PT rev (3m)41.91%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-82.84%
EPS NY rev (1m)0%
EPS NY rev (3m)194.94%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-13.18%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.18%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 15.99
P/S 0.53
P/FCF N/A
P/OCF N/A
P/B 3.52
P/tB 3.7
EV/EBITDA 23.42
EPS(TTM)0
EYN/A
EPS(NY)0.54
Fwd EY6.26%
FCF(TTM)-1.33
FCFYN/A
OCF(TTM)-0.99
OCFYN/A
SpS16.26
BVpS2.44
TBVpS2.32
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.1%
ROE -1.09%
ROCE 0.27%
ROIC 0.21%
ROICexc 0.25%
ROICexgc 0.25%
OM 0.3%
PM (TTM) N/A
GM 52.97%
FCFM N/A
ROA(3y)-1.15%
ROA(5y)-0.66%
ROE(3y)-9.56%
ROE(5y)-10.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.74%
GM growth 5Y-2.37%
F-Score1
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF N/A
Debt/EBITDA 3.58
Cap/Depr 113.43%
Cap/Sales 2.07%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.53
Quick Ratio 0.53
Altman-Z 0.72
F-Score1
WACC8.43%
ROIC/WACC0.03
Cap/Depr(3y)88.05%
Cap/Depr(5y)82.09%
Cap/Sales(3y)1.32%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%64.29%
EPS Next Y-61.36%
EPS Next 2Y120.89%
EPS Next 3Y112.9%
EPS Next 5YN/A
Revenue 1Y (TTM)1.66%
Revenue growth 3Y42.13%
Revenue growth 5Y10.73%
Sales Q2Q%5.89%
Revenue Next Year4.09%
Revenue Next 2Y9.2%
Revenue Next 3Y10.67%
Revenue Next 5YN/A
EBIT growth 1Y-77.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year185.49%
EBIT Next 3Y94.89%
EBIT Next 5YN/A
FCF growth 1Y-232.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-328.85%
OCF growth 3YN/A
OCF growth 5YN/A